Lepu Scientech Medical Technology Shanghai Co Ltd
HKEX:2291
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lepu Scientech Medical Technology Shanghai Co Ltd
Revenue
Lepu Scientech Medical Technology Shanghai Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lepu Scientech Medical Technology Shanghai Co Ltd
HKEX:2291
|
Revenue
¥471.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Revenue
¥2.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Revenue
¥7.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Revenue
¥33.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Revenue
¥1.6B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
16%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Revenue
¥10.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Lepu Scientech Medical Technology Shanghai Co Ltd
Glance View
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. operates as an investment holding company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-11-08. The firm operates primarily through two segments. The Occluder Business segment is mainly engaged in the research and development and sales of a series of interventional treatment series occluders for defective congenital heart disease. The Heart Valve Business segment is mainly engaged in the research and development of heart valve medical devices. The firm operates primarily in the domestic market.
See Also
What is Lepu Scientech Medical Technology Shanghai Co Ltd's Revenue?
Revenue
471.6m
CNY
Based on the financial report for Dec 31, 2024, Lepu Scientech Medical Technology Shanghai Co Ltd's Revenue amounts to 471.6m CNY.
What is Lepu Scientech Medical Technology Shanghai Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%
Over the last year, the Revenue growth was 44%. The average annual Revenue growth rates for Lepu Scientech Medical Technology Shanghai Co Ltd have been 28% over the past three years , 32% over the past five years .
